TI
CPRX

Tidal Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Tidal Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Sell
40,750
-4,559
-10% -$135K ﹤0.01% 1610
2026
Q1 		$1.12M Buy
+45,309
New +$1.08M ﹤0.01% 1420
2025
Q4 		– Sell
-44,040
Closed -$868K – 2176
2025
Q3 		$868K Sell
44,040
-2,176
-5% -$44.8K ﹤0.01% 1286
2025
Q2 		$1M Buy
46,216
+3,399
+8% +$80.2K 0.01% 1033
2025
Q1 		$1.04M Buy
42,817
+4,676
+12% +$105K 0.01% 964
2024
Q4 		$796K Sell
38,141
-1,905
-5% -$40.9K 0.01% 1130
2024
Q3 		$796K Hold
40,046
– – 0.01% 1120
2024
Q2 		$620K Buy
+40,046
New +$623K 0.01% 1176

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tidal Investments's CPRX Position: Q2 2026 in Review

Tidal Investments reduced its Catalyst Pharmaceutical (CPRX) stake by 10% in Q2 2026, selling an estimated $135K and leaving 40,750 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1610.

Tidal Investments first reported a position in CPRX in Q2 2024 and has held it in 8 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Tidal Investments held 40,750 shares of Catalyst Pharmaceutical worth $1.28M as of Q2 2026.
  • Tidal Investments sold 4,559 Catalyst Pharmaceutical shares in Q2 2026, an estimated $135K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1610 holding.
  • Tidal Investments first reported a position in Catalyst Pharmaceutical in Q2 2024 and has held it in 8 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.